En Es
Categories

MEDIX BIOCHEMICA AB

Develops, produces and markets monoclonal antibodies, antibody services and recombinant antigens for IVD industry, as well as POC testsĀ for human healthcare
Silver member
Products NewsSummary
Close

News of MEDIX BIOCHEMICA AB

Medix Biochemica Launches Refreshed and Expanding Brand to Reflect Growing IVD Products Portfolio

04 Mar 2022
Medix Biochemica Launches Refreshed and Expanding Brand to Reflect Growing IVD Products Portfolio
Medix Biochemica (Finland) is launching a rejuvenated brand to reflect both the improvements to its offering as a result of recent acquisitions, and its ongoing commitment to the in vitro diagnostics (IVD) industry.
Read More
Close

About MEDIX BIOCHEMICA AB

Number of Employees: 20-99
Year of Establishment: 1985
Develops, produces and markets monoclonal antibodies, antibody services and recombinant antigens for IVD industry, as well as POC testsĀ for human healthcare
FaceBook Twitter Google+ Linked in
Antibody Production Service

Antibody Production Service

Model: MedixMAB by Design
Request Information

Description:

The MedixMAB by Design offers a customized service for the in vitro generation of high-performance monoclonal recombinant antibodies and Fab fragments. The service is intended to offer a competitive advantage to IVD manufacturers.


Send A Message To This Supplier

* Required Information
* Email
To
MEDIX BIOCHEMICA AB (Antibody Production Service)
* Message

Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions